Interviews by Marie Lux give great insights on patients: How they think and what they really want. #3sixtypharmaSME? ?What patients really want https://twitter.com/3SixtyPharma/status/734089140237656064
University of Michigan The new study’s author,?J. Rebecca Liu, M.D., associate professor of obstetrics and gynecology at the University of Michigan, is quoted as saying?”In the past, we?ve thought (chemotherapy) resistance was caused by genetic changes in tumor cells. But we found that?s not the whole story.” ??@MHealthLab http://labblog.uofmhealth.org/lab-report/immune-cells-help-reverse-chemo-resistance-ovarian-cancer?? ?@3SixtyPharma ?#3SixtyPharmaSME
In 2014, FDA gave pembrolizumab accelerated approval for melanoma.? Today, the 3-year survival rate in melanoma patients is reported to be 40%.? ASCO president Dr. Julie Vose told NBC News, “This is something really different than what we have seen in the past.” ?nbcnews.to/25btTBv? via @nbcnews? @3SixtyPharma
Update to previous report (@NYTScience)?of scientists meeting at?Harvard Medical School to discuss?human genome synthesis. ?Today, New Scientist describes latest??leaked? details re: who, why, when… @3SixtyPharma ??@newscientist??http://ow.ly/SSnd300jXPz ?
New PhRMA-commissioned report: The US biopharmaceutical sector supports ~4.5 million jobs, contributes >$1.2 trillion, pays ~$311 B in wages/benefits. @PhRMA @3SixtyPharma